News

News
Partner news

Syndesi Therapeutics announces successful completion of first-in-human Phase I study of novel SV2A modulator, SDI-118, in development for the treatment of cognitive impairment.

Read full story
Partner news

ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes

Read full story
Partner news

Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders

Read full story
Partner news

On Target Laboratories secures $40 million financing led by Johnson & Johnson Innovation – JJDC, Inc. (JJDC)

Read full story
Partner news

ReVision Optics Raises $32 Million to Fund Expansion of U.S. Commercialization of Raindrop® Near Vision Inlay

Read full story
Partner news

Inivata and N-of-One Partner to Provide Personalized Genomic Interpretation and Clinical Trial Matching for Cancer Patients

Read full story
Partner news

Biosense Webster, Inc. Announces Acquisition of Coherex Medical, Inc.

Read full story
Partner news

First Aid Shot Therapy Rakes in $24 MM Series C

Read full story
Partner news

La Lumiere Closes $20 Million Series B Financing

Read full story
Partner news

Four Health Care IPOs: Nevro

Read full story
Partner news

Molecular Partners Has Successfully Priced its IPO Post Re-launch

Read full story
Partner news

CVRx® & DaVita Announce Strategic Partnership

Read full story
Partner news

Metabolex Gout Program Recognized in Windhover's Top 10 Most Interesting Projects to Watch

Read full story
Partner news

PhaseBio Launches Clinical Program to Test Lead Product for Sustained 24/7 Glycemic Control in Type 2 Diabetics

Read full story
Partner news

Syntaxin Raises £18 Million in New Financing

Read full story